{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreig7d3yoeus6xg6pcpk2b4omug4b6vayshvte5ue22wb66rqrtivlm",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mlojw35bi4i2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicinjlvfqocu6zemahbod324man23r5zw5fvtl3gbj7ftekcm7gdy"
    },
    "mimeType": "image/jpeg",
    "size": 105373
  },
  "path": "/news/2026-05-molecular-marker-prostate-cancer-treatment.html",
  "publishedAt": "2026-05-12T15:20:04.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Most prostate cancers rely on male sex hormones, known as androgens, to grow. As a result, standard treatment focuses on lowering androgen levels or blocking their activity, but many tumors eventually become resistant and the disease returns.",
  "title": "Novel molecular marker may improve prostate cancer treatment"
}